semaglutide local Designing GLP-1 delivery: structural perspectives

A recent study in The New England Journal of Medicine, aimed to evaluate the safety and efficacy of Retatrutide (LY3437943) drug and found that it was effective in reducing a significant amount of body weight and produced weight loss at levels never seen before in a pair of phase 2 studies that together randomized more than 600 people with overweight or obesity, with or without type 2 diabetes

IV Therapy: Some opt for glutathione IV treatments for a quicker absorption rate

watch now Ro CEO Zach Reitano talks launch of Wegovy's GLP-1 pill Ro Co-Founder and CEO Zach Reitano joins 'Fast Money' to talk the launch of Wegovy's oral GLP-1 offering, demand for the pill, and its partnership with Novo Nordisk to distribute the medication